Roles of human CYP2A6 and rat CYP2B1 in the oxidation of (+)-fenchol by liver microsomes

By Miyazawa M.   Gyoubu K.  

Xenobiotica, Vol. 37, Iss. 9, 2007-09 ,pp. : 943-953

Informa Healthcare

Access to resources Recommend Favorite

Stereoselectivity in metabolism of ifosfamide by CYP3A4 and CYP2B6

By Lu3 H.   Wang4 J. J.   Chan K. K.   Philip P. A.  

Xenobiotica, Vol. 36, Iss. 5, 2006-05 ,pp. : 367-385

Informa Healthcare

Access to resources Recommend Favorite

Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4

By Coller J. K.   Somogyi A. A.   Bochner F.  

Xenobiotica, Vol. 29, Iss. 10, 1999-10 ,pp. : 973-986

Informa Healthcare

Access to resources Recommend Favorite

Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development

By Mori K.   Hashimoto H.   Takatsu H.   Tsuda-Tsukimoto M.   Kume T.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 415-422

Informa Healthcare

Access to resources Recommend Favorite

High-throughput screening to estimate single or multiple enzymes involved in drug metabolism: microtitre plate assay using a combination of recombinant CYP2D6 and human liver microsomes

By Yamamoto T.   Suzuki A.   Kohno Y.  

Xenobiotica, Vol. 33, Iss. 8, 2003-08 ,pp. : 823-839

Informa Healthcare

Access to resources Recommend Favorite